{"id":3212,"date":"2020-11-27T10:13:38","date_gmt":"2020-11-27T02:13:38","guid":{"rendered":"https:\/\/geneusmtc.com\/?p=3212"},"modified":"2021-04-08T10:36:26","modified_gmt":"2021-04-08T02:36:26","slug":"%e9%ab%98%e5%ae%89%e6%b0%8f%e7%97%87%e9%80%a0%e6%88%90%e8%a1%80%e5%a3%93%e9%a3%86%e5%8d%87","status":"publish","type":"post","link":"https:\/\/geneusmtc.com\/%e9%ab%98%e5%ae%89%e6%b0%8f%e7%97%87%e9%80%a0%e6%88%90%e8%a1%80%e5%a3%93%e9%a3%86%e5%8d%87\/","title":{"rendered":"\u9ad8\u5b89\u6c0f\u75c7\u9020\u6210\u8840\u58d3\u98c6\u5347"},"content":{"rendered":"
\u91d1\u99ac\u734e\u5c0e\u6f14\u5f35\u6bc527\u65e5\u665a\u9593\u56e0\u8f38\u8840\u611f\u67d3\u75c5\u6cc1\u5371\u6025\uff0c\u4ed6\u7684\u59bb\u5b50\u4e5f\u5c31\u662f\u91d1\u99ac\u5f71\u540e\u694a\u60e0\u59cd\u5341\u5206\u50b7\u5fc3\uff0c\u5f35\u6bc5\u6700\u5f8c\u80fd\u7531\u65bc\u591a\u91cd\u5668\u5b98\u8870\u7aed\u65bc11\u67082\u65e5\u75c5\u901d\uff0c\u4eab\u5e7469\u6b72\u3002\u7d9c\u89c0\u5f35\u5c0e\u6f14\u7684\u4e00\u751f\u5341\u5206\u7cbe\u91c7\uff0c\u4f46\u56e0\u60a3\u6709\u7f55\u898b\u75be\u75c5\u9ad8\u5b89\u6c0f\u75c7\uff0c\u4e5f\u56e0\u6b64\u5c0e\u81f4\u4ed6\u4e00\u76f4\u8207\u75c5\u9b54\u7e8f\u9b251<\/sup>\u3002<\/p>\n \u4ec0\u9ebc\u662f\u9ad8\u5b89\u6c0f\u75c7\u5462? \u9ad8\u5b89\u6c0f\u75c7\u53c8\u7a31\u9ad8\u5b89\u6c0f\u52d5\u8108\u708e\uff08Takayasu arteritis\uff0cTA\uff09\u662f\u4e00\u7a2e\u4e3b\u52d5\u8108\u53ca\u5176\u4e3b\u8981\u5206\u652f\u8207\u80ba\u52d5\u8108\u7684\u6162\u6027\u9032\u884c\u6027\u7684\u767c\u708e\u53cd\u61c9\u3002\u6b64\u75be\u75c5\u7531\u65e5\u672c\u91ab\u751f\u9ad8\u5b89\u53f3\u4eba\u65bc1908\u5e74\u9996\u6b21\u5831\u544a\uff0c\u56e0\u6b64\u5f97\u540d2<\/sup>\u3002<\/p>\n \u570b\u5167\u53f0\u5317\u69ae\u6c11\u7e3d\u91ab\u9662\u5916\u79d1\u90e8\u6307\u51fa\u56e0\u70ba\u9ad8\u5b89\u6c0f\u75c7\u662f\u4e00\u7a2e\u4fb5\u72af\u4e3b\u52d5\u8108\u53ca\u5176\u5927\u5206\u679d\u7684\u8840\u7ba1\u708e\uff0c\u6700\u5f8c\u6703\u4f7f\u8840\u7ba1\u72f9\u7a84\u3001\u9589\u9396\u3001\u8840\u6813\u6216\u52d5\u8108\u7624\u5f62\u6210\uff0c\u7576\u7136\u4e5f\u6703\u4f7f\u8840\u58d3\u4e0a\u5347\u3002\u6b64\u75c5\u767c\u751f\u7387\u7d04\u767e\u842c\u5206\u4e4b3\u5de6\u53f3\uff0c \u4e14\u4e9e\u6d32\u4eba\u5c45\u591a\uff0c\u76ee\u524d\u7684\u4e3b\u8981\u6aa2\u67e5\u65b9\u5f0f\uff0c\u4f9d\u7136\u662f\u63a1\u75281990\u5e74\u7f8e\u570b\u98a8\u6fd5\u75c5\u5b78\u6703\u63d0\u51fa\u7684\u6a19\u6e96\uff1a<\/p>\n \u53ea\u8981\u6eff\u8db3\u4e0a\u8ff0\u4e09\u689d\u6216\u4ee5\u4e0a\u5373\u53ef\u8a3a\u65b7\u70ba\u9ad8\u5b89\u6c0f\u75c7\u3002<\/p>\n \u5728\u6cbb\u7642\u65b9\u9762\uff0c\u4ee5\u85e5\u7269\u6cbb\u7642\u4f86\u8aaa\u76ee\u524d\u9084\u662f\u4ee5\u985e\u56fa\u9187\u53ca\u5176\u4ed6\u514d\u75ab\u6291\u5236\u5291\u70ba\u4e3b\uff1b\u624b\u8853\u6cbb\u7642\u5247\u4fdd\u7559\u7d66\u75c7\u72c0\u56b4\u91cd\u7684\u75c5\u4eba\u4f7f\u75283<\/sup>\u3002\u7f8e\u570b\u570b\u5bb6\u885b\u751f\u7814\u7a76\u7684\u6307\u5f15\u5247\u8a8d\u70ba\u63a7\u5236\u767c\u708e\u53cd\u61c9\u53ca\u9ad8\u8840\u58d3\u662f\u76ee\u524d\u6cbb\u7642\u9ad8\u5b89\u6c0f\u75c7\u7684\u4e3b\u8981\u65b9\u54114<\/sup>\u3002<\/p>\n \u4e00\u7bc7\u57282018\u5e74\u767c\u8868\u65bc\u7f8e\u570b\u570b\u5bb6\u79d1\u5b78\u9662\u9662\u520a\u7684\u6587\u7ae0\u4e2d\u5c0d\u65bc\u9ad8\u5b89\u6c0f\u75c7\uff0c\u6709\u66f4\u9032\u4e00\u6b65\u7684\u4e86\u89e3\uff1a\u96d6\u7136\u76ee\u524d\u9ad8\u5b89\u6c0f\u75c7\u662f\u4e00\u7a2e\u539f\u56e0\u4e0d\u660e\u7684\u5168\u8eab\u6027\u8840\u7ba1\u708e\uff0c\u5728\u5df2\u77e5\u7814\u7a76\u4e2d\u8a8d\u70baHLA-B*52\u57fa\u56e0\uff0c(HLA-human leukocyte antigen\u7a31\u70ba\u4eba\u985e\u767d\u8840\u7403\u6297\u539f\uff0c\u662f\u4e00\u7a2e\u6703\u5f71\u97ff\u4eba\u985e\u514d\u75ab\u7cfb\u7d71\u7684\u57fa\u56e0)\u7684\u57fa\u56e0\u8b8a\u7570\u662f\u9ad8\u5b89\u6c0f\u75c7\u7684\u4e3b\u56e0\u3002\u4f46\u662f\u5728\u6b64\u6b21\u7814\u7a76\u4e2d\u767c\u73fe\u9ad8\u5b89\u6c0f\u75c7\u8207\u5176\u4ed6\u975eHLA\u7684\u57fa\u56e0\u8b8a\u7570\u4e5f\u6709\u9ad8\u5ea6\u95dc\u4fc2\uff0c\u4f8b\u5982PTK2B<\/em>\uff0cLILRA3\/LILRB2<\/em>\uff0cDUSP22<\/em>\u53caKLHL33<\/em>\uff0c\u800c\u4e14\u7531\u65bc\u9019\u4e9b\u57fa\u56e0\u8207\u4e00\u7a2e\u7a31\u70ba\u4eba\u985e\u81ea\u7136\u6bba\u624b\u7d30\u80de\u7684\u514d\u75ab\u7d30\u80de\u6709\u95dc\uff0c\u66f4\u8b49\u5be6\u4e86\u9ad8\u5b89\u6c0f\u75c7\u548c\u514d\u75ab\u7570\u5e38\u7684\u95dc\u806f5<\/sup>\u3002<\/p>\n \u6676\u6e96\u91ab\u5b78\u79d1\u6280\u7684\u5065\u5eb7\u5148\u77e5\u5b8c\u6574\u7248\u5c0d\u65bc\u9ad8\u5b89\u6c0f\u75c7\u7684\u57fa\u56e0\uff0c\u90fd\u63d0\u4f9b\u4e86\u6700\u5148\u9032\u5b9a\u5e8f\u53ca\u5224\u8b80\u7684\u670d\u52d9\uff0c\u60f3\u5c0d\u9ad8\u5b89\u6c0f\u75c7\u505a\u5fb9\u5e95\u57fa\u56e0\u6aa2\u6e2c\uff0c\u90fd\u6b61\u8fce\u8207\u6211\u5011\u5c08\u696d\u4eba\u54e1\u806f\u7d61\u3002<\/p>\n #\u9ad8\u5b89\u6c0f\u75c7# HLA-B*52<\/em>\u57fa\u56e0# PTK2B<\/em>\u57fa\u56e0# LILRA3\/LILRB2<\/em>\u57fa\u56e0 # DUSP22<\/em>\u57fa\u56e0# KLHL33<\/em>\u57fa\u56e0#\u5065\u5eb7\u5148\u77e5\u5b8c\u6574\u7248<\/p>\n <\/p>\n \u53c3\u8003\u8cc7\u6599\uff1a<\/p>\n \u5c0d\u65bc\u6211\u5011\u7684\u7522\u54c1\u8cc7\u8a0a\u9084\u6709\u7591\u60d1\u55ce\uff1f<\/span><\/p>\n \u6b61\u8fce\u8a62\u554f\u6211\u5011\u5c08\u696d\u7684\u91ab\u5b78\u5ba2\u670d\u5c08\u54e1\uff0c\u6211\u5011\u6703\u76e1\u5feb\u8207\u60a8\u806f\u7d61\u3002<\/span><\/p>\n<\/div>\n
\n
\u806f\u7d61\u6676\u6e96<\/span><\/h2>\n<\/div>